Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Revenue | 560.00K | 490.00K | 396.60K | 260.80K | 150.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 560.00K | 490.00K | 396.60K | 260.80K | 150.00K |
| Cost of Revenue | 54.50K | 54.80K | 68.70K | 59.70K | 46.20K |
| Gross Profit | 505.40K | 435.10K | 327.80K | 201.00K | 103.80K |
| SG&A Expenses | 970.90K | 938.80K | 1.16M | 1.15M | 1.98M |
| Depreciation & Amortization | 45.40K | 30.00K | 15.00K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.07M | 1.02M | 1.25M | 1.21M | 2.03M |
| Operating Income | -510.70K | -533.50K | -852.00K | -948.10K | -1.88M |
| Income Before Tax | -5.11M | -2.78M | -2.80M | -2.14M | -3.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.11 | -2.78 | -2.80 | -2.14 | -3.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 205.20K | 205.20K | 205.20K |
| Net Income | -5.12M | -2.79M | -2.60M | -1.94M | -3.12M |
| EBIT | -510.70K | -533.50K | -852.00K | -948.10K | -1.88M |
| EBITDA | -449.80K | -488.10K | -821.60K | -932.70K | -1.86M |
| EPS Basic | -0.02 | -0.02 | -0.04 | -0.05 | -0.09 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.05 | -0.09 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 |
| Average Basic Shares Outstanding | 8.91B | 3.52B | 1.04B | 192.73M | 162.99M |
| Average Diluted Shares Outstanding | 8.91B | 3.52B | 1.04B | 192.73M | 162.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
